LOW GRADE GLIOMA
Clinical trials for LOW GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE GLIOMA trials appear
Sign up with your email to follow new studies for LOW GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted drug shows promise for kids with rare, recurrent cancers
Disease control CompletedThis study tested a drug called tazemetostat in 20 children and young adults whose cancers had returned or stopped responding to treatment. Only patients whose tumors had specific gene changes (EZH2, SMARCB1, or SMARCA4) were included. The goal was to see if the drug could shrink…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
New hope for kids with tough brain tumors: experimental drug shows promise
Disease control CompletedThis study tested a drug called Tovorafenib in 44 children and young adults with low-grade gliomas (a type of brain tumor) that had come back or grown despite other treatments. The main goal was to find the safest dose and check for side effects. The drug works by blocking a spec…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE1 • Sponsor: Karen D. Wright, MD • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
New dye could sharpen brain tumor detection
Diagnosis CompletedThis study tested a special dye called fluoroethyltyrosine (FET) used in PET scans to see if it can better detect brain tumors that have come back. Researchers studied 143 people with different types of brain tumors to measure how accurate the FET PET scan is compared to standard…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 01, 2026 15:40 UTC